J30-8 is a potent and subtype-selective JNK3 inhibitor with an IC50 value of 40 nM, exhibiting 2500-fold selectivity over JNK1α1 and JNK2α2 subtypes; it demonstrates neuroprotective activity in vitro and holds potential for the study of neurodegenerative diseases.